Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 473 All time
- Disclosed funding
- $19.6B 400 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| B BioLinkerCompany profile BioLinker develops and manufactures recombinant proteins and synthetic-biology tools. BioLinker develops and manufactures recombinant proteins and synthetic-biology tools. | R$8.4M | Funding with PIPE grantUndisclosed | Biotech | Brazil | Investors | |
| CT Celaid TherapeuticsCompany profile Celaid Therapeutics develops cell therapies using technology that expands blood-forming stem cells outside the body. Celaid Therapeutics develops cell therapies using technology that expands blood-forming stem cells outside the body. | ¥400M | Series B second closeSeries B | Biotech | Japan | Investors | |
| O OmnioCompany profile Omnio develops a plasminogen-based biologic for chronic wounds, initially diabetic foot ulcers. Omnio develops a plasminogen-based biologic for chronic wounds, initially diabetic foot ulcers. | €2.9M | Funding roundUndisclosed | Biotech | Sweden | Investors Undisclosed | |
| M M-BasedCompany profile Ankara biomaterials company developing mushroom-based alternatives for industrial products. Ankara biomaterials company developing mushroom-based alternatives for industrial products. | ~$700K | Seed | Biotech, Climate tech | Türkiye | Investors | |
| AB Aptatek Biosciences, Inc.Company profile Aptatek Biosciences develops connected diagnostic tools for metabolic monitoring at home. Its investigational PheCheck programme measures blood phenylalanine for people with PKU. Aptatek Biosciences develops connected diagnostic tools for metabolic monitoring at home. Its investigational PheCheck programme measures blood phenylalanine for people with PKU. | Undisclosed | Initial close of financingUndisclosed | Biotech | United States | Investors | |
 AventixCompany profile Aventix builds sensor-based analytical instruments for laboratories. Its first product, Scarlett 01, measures liquid volumes across microplate wells without touching the sample, helping R&D teams check dispensing quality and catch volume variation before it affects assay results. Aventix builds sensor-based analytical instruments for laboratories. Its first product, Scarlett 01, measures liquid volumes across microplate wells without touching the sample, helping R&D teams check dispensing quality and catch volume variation before it affects assay results. | €1.2M | Pre-seed | Biotech | Sweden | Investors | |
| AP Astrocyte Pharmaceuticals Inc.Company profile Astrocyte Pharmaceuticals develops treatments intended to protect brain tissue after concussion, traumatic brain injury and stroke by targeting astrocytes. Astrocyte Pharmaceuticals develops treatments intended to protect brain tissue after concussion, traumatic brain injury and stroke by targeting astrocytes. | $9.5M | Series B | Biotech | United States | Investors | |
| V VytalyouCompany profile Vytalyou provides doctor-led preventive-health services combining diagnostics, personalised interventions and medically supervised care. Vytalyou provides doctor-led preventive-health services combining diagnostics, personalised interventions and medically supervised care. | ₹90M | Pre-Series ASeed | Biotech, Healthtech | India | Investors | |
 AnaCardioCompany profile AnaCardio develops oral medicines intended to improve heart muscle contraction in people with heart failure. AnaCardio develops oral medicines intended to improve heart muscle contraction in people with heart failure. | €62.5M | Series B | Biotech | Sweden | Investors | |
| AT Aptadir TherapeuticsCompany profile RNA therapeutics designed to restore expression of silenced genes RNA therapeutics designed to restore expression of silenced genes | €40M | Seed | Biotech | Italy | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1RA Capital Management
Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology
22rounds3led - 2Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
15rounds1led - 3Eli Lilly and Company
BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences
15rounds0led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
14rounds0led - 5OrbiMed
Star Therapeutics, Leal Therapeutics, Accro Bioscience
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →